Richard L. Lindstrom M.D. is Director at OCULAR THERAPEUTIX, INC (OCUL). They have made 8 open-market trades across 3 companies since 2016, most recently 2026-06-10.
CIK 0001242177
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $1.2M since 2016, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OCUL | 260,933 | $1.8M |
| LNSR | 263,831 | $1.5M |
| HROW | 26,100 | $712K |
| IMMY | 100,000 | $569K |
| ONMD | 73,496 | $348K |
| TEAR | 66,666 | $46K |
| TLCV | 29,500 | — |
| Total | $5.0M |
Shares reported on the most recent Form 4, priced at the 2026-06-12 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCUL | BUY | 2026-02-20 | 2026-02-24 | $7.66 | $461K | +10.6% | -13.2% | -10.6% |
| OCUL | BUY | 2025-05-08 | 2025-05-12 | $6.96 | $70K | -3.4% | +18.1% | +68.1% |
| HROW | SELL | 2022-09-30 | 2022-10-03 | $12.62 | $1.0M | -8.2% | -6.4% | +12.4% |
| HROW | SELL · 10b5-1 | 2021-09-24 | 2021-09-27 | $10.04 | $39K | +1.5% | +0.6% | -4.3% |
| HROW | SELL | 2021-09-15 | 2021-09-17 | $9.07 | $363K | -0.2% | +13.2% | -5.7% |
| HROW | SELL | 2021-05-20 | 2021-05-21 | $10.75 | $108K | -6.3% | -16.1% | -15.1% |
| OCUL | SELL | 2021-05-20 | 2021-05-21 | $14.30 | $143K | +5.6% | +2.0% | -29.0% |
| OCUL | BUY | 2019-03-13 | 2019-03-14 | $4.33 | $489K | -4.5% | -11.9% | -9.3% |
| IMMY | BUY | 2016-12-19 | 2016-12-21 | $1.79 | $179K | +20.8% | +30.2% | +14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.